Avolta Partners advised BID Equity Fund III on its acquisition of ARS Nova SAS, operating as TinyMDM, a leading provider of Mobile Device Management (MDM) solutions. With BID Equity as a strong partner, TinyMDM is ideally positioned for further international expansion and sustained growth.
TinyMDM now forms the foundation of a new international software group focused on the management and security of technological endpoints. By joining forces with BID Equity, TinyMDM is supported by a strong financial and strategic partner, enabling further market development and innovation.
About TinyMDM (ARS Nova SAS)
TinyMDM is a leading provider of Mobile Device Management solutions based in France. Its cloud-based platform allows companies to securely manage, monitor, and control corporate mobile devices at scale. Trusted by organizations across healthcare, education, transportation, retail, and public administration, TinyMDM combines advanced technology with user-friendly interfaces to set new standards for security and efficiency in mobile device management.
About BID Equity
BID Equity advises the BID Equity funds, specializing in investments in successful B2B software companies. The funds focus on acquiring majority shareholdings in the context of company successions and shareholder buy-outs of small to medium-sized software companies in Europe. BID Equity takes an active investment approach, partnering with management teams to optimize product offerings, business models, and processes while pursuing international growth opportunities.
About Avolta
Avolta is a leading European tech investment bank with recognized expertise in software transactions. Advising BID Equity in this acquisition of TinyMDM sets another landmark for Avolta in the software space, confirming its leadership, having recently advised Elevo on its acquisition by Assessio (Pollen Street Capital), Fluid Topics on its €15m Series B with Kennet, Unifai on its sale to Akeneo (Summit Partners), Dartagnan on its sale to JustRelate (BID Equity) and Opendatasoft in its €21m Series B.
